after VTP with only 2 mice presenting levels >0.1. After 4 weeks, one mouse still had undetected PSA (<0.1) CONCLUSIONS: In a preclinical prostate cancer model using VTP ablation, we show that RSOM and 68 Ga-PSMA PET-CT are promising imaging approaches. We demonstrate that RSOMmeasured vessels density can predict the success of ablation before VTP and 68 Ga-PSMA PET-CT signal can predict relapse after VTP ablation, that outperform blood PSA level.
INTRODUCTION AND OBJECTIVES: Apparent diffusion coefficient (ADC) is expected to reflect tumor aggressiveness. In prostate cancer (PC), however, the use of ADC value (ADCV) is limited to the peripheral zone (PZ) because of the background signal, especially in the transition zone (TZ). We assessed the usefulness of ADC ratio (ADCR) in predicting ISUP grade groups on radical prostatectomy (RP-GG) and subsequent biochemical recurrence (BCR) by prostatic zone.
METHODS: We enrolled 284 clinically localized PC patients who had undergone multiparametric MRI, systematic biopsy, and RP. A region of interest (ROI) was drawn outlining the index tumor on ADC map. Another equal-sized ROI was drawn symmetrically in the contralateral lobe and adjusted to include normal regions if necessary. ADCR was calculated by dividing the tumor ADCV by the contralateral ADCV. ADC metrics were examined for associations with RP-GG and BCR using Spearman's coefficient and logistic or Cox regression, and their predictive ability was assessed using the area under the curve (AUC) or concordance (c-) index. Cutoffs of variables were set to obtain their best performance.
RESULTS: In total (TZ/PZ [ 103/181, RP-GG1/2/3/!4 [ 25/ 146/70/43), 76 men (27%) had BCR at a median follow-up of 68 months. ADCV and ADCR inversely correlated with RP-GG in TZ (r [ -0.42 and -0.55, each p<0.001) The use of MRI assistance in the diagnosis and surveillance of men with prostate cancer has become increasingly more widespread. The aim of our study was to determine the rate of pathology upgrading in men when MRI-guided fusion biopsy (FBx) is used after regular systematic/template biopsy (TRUS Bx), and to determine factors predictive of upgrading.
METHODS: We conducted a retrospective review of all patients who underwent FBx (targeted MRI lesion plus 12-core template biopsy) at our institution between 2015 and 2018. Only patients with previous diagnosis of atypical small acinar proliferation (ASAP) or on active surveillance for prostate cancer diagnosed and previously surveyed by TRUS Bx were included. Any patients with >3 years between regular and FBx were excluded. Patient demographic data included age, number of regular biopsies before FBx, PIRADS grading of MRI lesion, PSA immediately prior to FBx, and time interval between regular and MRI biopsy. Outcome was rate of upgrading between TRUS Bx and FBx. Upgrading was defined as increase in Gleason grade and/or new positive core in a different prostate region on FBx. Vol. 201, No. 4S, Supplement, Monday, May 6, 2019 THE JOURNAL OF UROLOGY Ò e1163
Chi-square and logistic regression models were used to determine significance. RESULTS: 294 patients underwent FBx and 33 (11. 2%) met inclusion criteria. Average age was 65.9 (AE5.98) years. Median number of biopsies was 1 (range 1-4). Median PIRADS score was 4.0 (range 2-5) and median PSA prior to MRI biopsy was 5.20 (range 1.39-34.52). Average time interval between regular and MRI biopsies was 12.31 AE 7.34 months. 19 patients (57.6%) were upgraded on FBx, 11 (33.3%) downgraded, and 3 (9. 1%) with the same grading. Using MRI template biopsy alone, 16 patients (48.5%) were upgraded. When using MRI lesion biopsy only, 14 (42.4%) were upgraded. These differences in detection compared to combined MRI lesion plus template biopsy were not statistically significant (p[0.93 and 0.84, respectively) . When comparing upgraded to downgraded patients, PIRADS score was significantly higher in the upgraded group (4.06 vs. 3.20, p [0.008). On multivariable analysis, there were no significant factors predictive of FBx upgrading.
CONCLUSIONS: Previously published literature has shown an upgrading rate of about 30% between first and subsequent prostate biopsy. However, with the use of MRI, over half of our patients had upgrading. Biopsy of the MRI lesion alone would have missed 26% of patients with upgrading, emphasizing that template biopsy is still warranted at the time of fusion biopsy. Further studies with larger cohorts are needed to validate to our results.
Source of Funding: None.
MP80-09 MINIMAL RESIDUAL MEMBRANOUS URETHRAL LENGTH AND MEMBRANOUS URETHRAL LENGTH CAN BE PREDICTIVE FACTORS FOR POOR RECOVERY FROM INCONTINENCE AFTER RADICAL PROSTATECTOMY
Eiichiro Ohara*, Naoki Kawamorita, Sendai, Japan; Hideo Saito, Shigeto Ishidoya, Sendai, Japan; Yoichi Arai, Natori, Japan INTRODUCTION AND OBJECTIVES: Post-operative urinary incontinence (PUI) is a common comorbidity following robot-assisted radical prostatectomy (RARP) or open radical prostatectomy (ORP). We previously reported a novel preoperative predictor, minimal residual membranous urethral length (mRUL), defined as the distance between the lower margins of the puboperinealis and bulbospongiosus muscles parallel with the urethra on preoperative magnetic resonance imaging (MRI). In the present study, we examined each parameter predicting postoperative recovery from PUI after RARP and ORP.
METHODS: From 2007 to 2010 and from 2012 to 2016, a total of 111 and 198 patients were treated with ORP or RARP respectively at our institution. Patients underwent 3-T pelvic MRI for preoperative evaluation of prostate cancer. All patients completed the EPIC instrument before and at 1, 3, 6 and 12 months after surgery. Patients reporting "rarely or never" were defined as being continent. The MRI parameters mRUL and membranous urethral length (MUL) were measured and analyzed along with several other factors such as age, BMI, and nerve preservation.
RESULTS: Median values for mRUL and MUL were 7.81 mm (IQR: 6.56 to 9.25) and 14.27 mm (IQR: 12.12 to 16.46) respectively in RARP patients. On the other hand, median values for mRUL and MUL were 7.15 mm (IQR: 6.18 to 8.24) and13.57 mm (IQR: 11.28 to 15.81) respectively in OPR patients. The recovery rates from PUI were similar for both groups. Multivariate analyses indicated that mRUL was a predictor of baseline continence, whereas MUL was a significant predictor of poor recovery from PUI (Table 1) . When patients were classified using the median mRUL and MUL values, patients with both short mRUL and MUL group had significantly poorer recoveries from PUI after RARP and ORP (Fig.1) .
CONCLUSIONS: The mRUL and MUL measured by preoperative MRI can predict poor recovery from PUI after radical prostatectomy. Therefore, health providers should provide patients with this important information prior to surgery. INTRODUCTION AND OBJECTIVES: Differentiating benign from malignant masses using enhancement alone can be difficult. Additional imaging metrics (e.g. tumor shape and texture) have been shown to improve discrimination. Using a computer algorithm to quantitatively analyze shape and texture features of renal tumors in three dimensions on routine imaging, we created an objective non-invasive method to evaluate tumor behavior. We tested this radiomics framework in objectively distinguishing between benign and malignant renal masses on imaging. We also determined whether shape shows independency from texture in discriminating benign from malignant masses.
METHODS: Multiphase computed tomography (CT) images of 135 patients with 94 malignant and 41 benign masses diagnosed between 2011 and 2014 were segmented. Point coordinates of tumor contours in all axial slices were input into a MATLAB (MathWorks) algorithm. 33 shape metrics and 760 texture metrics were calculated per tumor. We used least absolute shrinkage and selection operator (LASSO) to nominate important shape and texture metrics respectively in discriminating benign and malignant masses, and we used lambda value to constrain the model size under 4 predictors. Area under the curve (AUC) was used to assess discrimination power. We conducted Z test between shape and texture metrics to investigate the independency of shape and texture from each other. SAS 9.4 was used for all data analysis.
